United States · FDA National Drug Code directory
Betaloan SUIK
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 80425-0347_2a9c3847-6363-8f9e-e063-6394a90a15c9
- Product NDC
- 80425-0347
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Betamethasone Sodium Phosphate and Betamethasone Acetate
- Labeler
- Advanced Rx Pharmacy of Tennessee, LLC
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start / end (source format)
- 20230726
- Source listing expiry
- 20261231
Source-listed ingredients
- BETAMETHASONE SODIUM PHOSPHATE — 3 mg/mL
- BETAMETHASONE ACETATE — 3 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (80425-0347-1) / 5 mL in 1 VIAL, MULTI-DOSE · 80425-0347-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →